New test predicts risk for recurrence for patients with DCIS
Wednesday, December 7, 2011 - 05:30
in Health & Medicine
In a significant advance for patients with ductal carcinoma in situ, researchers have developed and prospectively validated a multigene test to identify the risk for recurrence of breast cancer.